← Back to headlines
Pfizer Targets Post-2028 Growth with New Obesity and Cancer Drugs
Pharmaceutical giant Pfizer is banking on its new obesity and cancer drugs to drive a return to growth for the company after 2028.
5 May, 17:30 — 5 May, 17:30
Sources
Showing 1 of 1 sources
Related Stories
What we know about the deadly flooding on the Nepal-Tibet border
7m ago
Two German Airport Workers Die in Rare Malaria Outbreak Linked to Imported Mosquitoes
21m ago
Deadly Flash Floods Sweep Northern Nepal, Leaving Hundreds Missing
27m ago
Boating Accidents in Sweden and India Leave Multiple People Missing and Require Rescue
29m ago